Delivery Order SPE2DB22D2206-SPE2DB25FJH84
Award Date 8/11/25
Potential Completion Date 9/2/25
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a $10,518.48 delivery order to AmerisourceBergen Drug Corp for the supply of Benlysta 400 mg vials, with an ultimate completion date of August 12, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical federal medical procurement vendor for military and veteran healthcare...
- The Defense Logistics Agency awarded a $34,196.40 delivery order to AmerisourceBergen Drug Corp for 400 mg vials of Benlysta, a therapeutic pharmaceutical used primarily in the treatment of systemic lupus erythematosus. This firm fixed-price delivery order, awarded on September 22, 2025, with an ultimate completion date of October 14, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award carries no set-aside...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for $7,888.86 in Benlysta 400 mg vials on September 26, 2025, with an ultimate completion date of October 20, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger pharmaceutical supply relationship with the Defense Logistics Agency. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a $2,629.64 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Benlysta 400 mg vials, with a completion date of June 24, 2025. This non-set-aside contract was competitively awarded on June 2, 2025, and represents a child order under AmerisourceBergen's larger pharmaceutical supply framework with DLA. The product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,330.68 for Benlysta 200 mg/ml auto-injectors, with an ultimate completion date of September 25, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is located in Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,999.36 for Benlysta 400 mg vials, with an ultimate completion date of June 23, 2025. This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a $10,518.48 firm fixed price delivery order to AmerisourceBergen Drug Corp for 400 mg vials of Benlysta, a biologic medication used to treat systemic lupus erythematosus and lupus nephritis. The order was competitively awarded without set-aside designation and is scheduled for completion by September 23, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this delivery order from its corporate office location. This delivery...
- The Defense Logistics Agency awarded a $10,258.92 delivery order to AmerisourceBergen Drug Corp for 400 mg vials of Benlysta, a biologic medication used to treat systemic lupus erythematosus and other autoimmune conditions. This firm fixed-price delivery order, issued on April 24, 2025, with an ultimate completion date of May 15, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was competitively...
- The Defense Logistics Agency awarded a $12,305.60 delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml syringes, with an ultimate completion date of October 1, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is one of the nation's largest pharmaceutical distributors and serves as a critical vendor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a $12,330.68 delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injector pharmaceutical supply. The contract, issued on August 8, 2025, with an ultimate completion date of August 29, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger...